Skip to Content

Valsartan Tablets

Last Updated: March 13, 2013
Status: Resolved

Products Affected - Description

Diovan tablets, Novartis
40 mg, 100 count, unit-dose (NDC 00078-0423-06) - discontinued
80 mg, 100 count, unit-dose (NDC 00078-0358-06) - discontinued
80 mg, 14000 count, (NDC 00078-0358-33) - discontinued
160 mg, 100 count, unit-dose (NDC 00078-0359-06) - discontinued
160 mg, 7000 count, (NDC 00078-0359-17) - discontinued
320 mg, 3500 count (NDC 00078-0360-11) - discontinued

Reason for the Shortage

  • Novartis is the sole supplier of valsartan tablets.
  • Novartis could not provide a reason for the shortage.
  • Novartis discontinued the unit dose and larger count presentations in late 2012.

Available Products

Diovan tablets, Novartis
40 mg, 30 count (NDC 00078-0423-15)

80 mg, 90 count (NDC 00078-0358-34)
160 mg, 90 count (NDC 00078-0359-34)
320 mg, 90 count, (NDC 00078-0360-34)

Estimated Resupply Dates

All Diovan presentations are available.

Related Shortages

Updated

March 13, 2013; February 1, 2013; December 17, 2012; October 9, 2012; July 25, 2012; July 5, 2012; June 6, 2012; May 29, 2012; May 9, 2012; April 13, 2012; March 23, 2012; March 8, 2012; February 17, 2012; February 3, 2012; January 27, 2012, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide